SMaRT FVIII (VIRxSYS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSMaRT FVIII (VIRxSYS)

Drug Alias NameFactor VIII modulator (VIRxSYS)hemophilia therapeutic (VIRxSYS)Factor VIII modulator (Intronn)hemophilia therapeutic (Intronn)SMaRT FVIII (Intronn)

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionCoagulation factor VIII modulators

TargetsCoagulation factor VIII

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIntronn Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIntronn Inc Virxsys Corp

Active IndicationsN/A

Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A